FDA panel: No cold meds for under-6 kids

The concerns about cough-and-cold meds for kids culminated Friday in an FDA advisory group vote against the products. The expert group concluded that there's not enough evidence that the drugs work--and plenty of evidence that they can be harmful--so they shouldn't be used in children under the age of 6.

The 13-to-9 decision was by no means unanimous, though. Some panelists believe parents depend on the drugs for help when a child is sick. Americans spend more than $300 million a year on these products. The agency probably will work with the industry to come up with a voluntary action plan, because formal proceedings could take years, FDA officials told the Washington Post.

- read the report from the Washington Post

Related Articles:
FDA experts mull ban on child cold meds. Report
Drug makers recall infant cold meds. Report
FDA to review OTC cough medicine safety. Report

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.